The Board proposes the rule amendment to update the rule to require interns to report to the Board when their eligibility status changes.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-26.400Pharmacy Interns; Registration; Employment

PURPOSE AND EFFECT: The Board proposes the rule amendment to update the rule to require interns to report to the Board when their eligibility status changes.

SUMMARY: Interns will be required to report to the Board when their eligibility status changes.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 465.005 FS.

LAW IMPLEMENTED: 465.013 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Jennifer Wenhold, Acting Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B16-26.400 Pharmacy Interns; Registration; Employment.

(1) through (4) No change.

(5) Within thirty (30) days of termination of enrollment in an intern program, or withdrawal of registration or attendance in an accredited school or college of pharmacy, all registered pharmacy interns shall report such change in enrollment, registration or attendance to the Board office.  The notification may include a request, including full explanation and supported by accompanying documentation, if any, that the pharmacy intern registration not be cancelled pending the registered pharmacy intern’s re-enrollment, re-registration, or re-attendance in an accredited intern program or accredited school or college of pharmacy.

Rulemaking Authority 465.005 FS. Law Implemented 465.003(12), 465.013 FS. History–Amended 8-20-63, 5-19-72, 8-18-73, Repromulgated 12-18-74, Amended 11-10-80, 4-30-85, Formerly 21S-1.21, Amended 10-20-88, Formerly 21S-1.021, Amended 7-31-91, 1-10-93, Formerly 21S-26.400, 61F10-26.400, 59X-26.400, Amended 3-10-05,               .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: December 12, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: January 14, 2019